China Property Fatigue about easing expectation
–Release of pent-up demand as expected
2Q loss reduction trend better than expectation
We expect 1H24 to be still profitable
Expect higher ASP following China’s stimulus
1H24 preview: margin weakness priced in; expect gradual ASP/margin recovery in 2H
China Pharmaceutical & Healthcare - Expecting global funding recovery in the coming quarters
Apple FY1Q23 miss on macro and supply chain issues; Expect weakness to persist in near term
China Property Sector:NBS Sep data: gloomy as expected, no strong rebound, only mild recovery in 4Q in our view
A-Share Market Strategy Weekly: Market Expectations Going Up